These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9556053)

  • 21. Cytokines, growth factors and osteoclasts.
    Heymann D; Guicheux J; Gouin F; Passuti N; Daculsi G
    Cytokine; 1998 Mar; 10(3):155-68. PubMed ID: 9576060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro.
    Hattersley G; Chambers TJ
    J Cell Physiol; 1989 Sep; 140(3):478-82. PubMed ID: 2777887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Origin of osteoclasts].
    Jotereau F
    Ann Biol Clin (Paris); 1985; 43(5):767-72. PubMed ID: 4091325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cell biology of bone metabolism.
    Datta HK; Ng WF; Walker JA; Tuck SP; Varanasi SS
    J Clin Pathol; 2008 May; 61(5):577-87. PubMed ID: 18441154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the organization and regeneration of bone marrow: origin, growth, and differentiation of endocloned hematopoietic colonies.
    Lambertsen RH; Weiss L
    Am J Anat; 1983 Apr; 166(4):369-92. PubMed ID: 6858938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell therapy for disorders of bone.
    Jethva R; Otsuru S; Dominici M; Horwitz EM
    Cytotherapy; 2009; 11(1):3-17. PubMed ID: 19191055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
    Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
    Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion of red bone marrow into yellow - Cause and mechanisms.
    Gurevitch O; Slavin S; Feldman AG
    Med Hypotheses; 2007; 69(3):531-6. PubMed ID: 17433565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
    Rifas L; Arackal S; Weitzmann MN
    J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.
    Bar-Shavit Z
    J Cell Biochem; 2007 Dec; 102(5):1130-9. PubMed ID: 17955494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
    Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow.
    Kitamura H; Kawata H; Takahashi F; Higuchi Y; Furuichi T; Ohkawa H
    Am J Pathol; 1995 Dec; 147(6):1682-92. PubMed ID: 7495293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular cell adhesion molecule-1 expression by hematopoiesis-supporting stromal cells is not essential for lymphoid or myeloid differentiation in vivo or in vitro.
    Friedrich C; Cybulsky MI; Gutierrez-Ramos JC
    Eur J Immunol; 1996 Nov; 26(11):2773-80. PubMed ID: 8921968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue.
    Hattersley G; Chambers TJ
    J Cell Physiol; 1990 Jan; 142(1):201-9. PubMed ID: 2153687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.